183C91
National Institutes of Health
Papers overview
Semantic Scholar uses AI to extract papers important to this topic.
AbstractBackground and objective: Oral zolmitriptan is highly effective in the acute treatment of migraine. However, nausea and…
The objective of this study was to investigate the pharmacokinetics, dose proportionality, and tolerability of a range of single…
HeadingAbstract
Background. Zolmitriptan is a 5HT1B/1D receptor agonist effective in the acute treatment of migraine. Clinical…
Zolmitriptan is a serotonin 5-HT1B/1D receptor agonist that is highly effective for the acute treatment ofmigraine.[1] Following…
Two preliminary studies of the pharmacokinetics and tolerability of zolmitriptan nasal spray were conducted, each involving 12…
AIMS
Zolmitriptan (Zomig (formerly 311C90)) is a novel 5-HT1B/1D receptor agonist developed for the acute oral treatment of…
SummaryTwo studies were conducted in healthy volunteers to evaluate the effects of rifampicin and cimetidine on the…
Seven randomized studies in healthy volunteers have investigated interactions between zolmitriptan (Zomig™, formerly 311C90), a…
AbstractObjective: This study investigated potential pharmacokinetic or pharmacodynamic interactions between the novel anti…